US 7,442,772 B2 · Antibodies to PRO361 polypeptide

Abstract

The present invention is directed to secreted and transmembrane polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims4

Dependent claims

An isolated antibody that binds to the polypeptide shown in FIG. 32 (SEQ ID NO:83).

Dependencies are inferred from the claim text.

Facts

Application

10/735,014Filed 12 Dec 2003 · continuation

Priority

25 Feb 1998

Published

US 2004/0220385 A14 Nov 2004

Granted

28 Oct 2008

Term ends

Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07K 14/47
From vertebrates: from mammals
C07K 14/705
From animals; from humans: receptors; Cell surface antigens; Cell surface determinants
C07K 16/18
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies: against material from animals or humans
C07K
Peptides

Family

Application60/075,945Us provisional application · filed 25 Feb 1998

PCT/US98/25108Parent of this continuation-in-part · filed 1 Dec 1998

PCT/US99/28301Parent of this continuation · filed 1 Dec 1999

Application09/866,028Parent of this continuation · filed 25 May 2001

Application09/944,852Parent of this continuation · filed 31 Aug 2001

US 2004/0220385 A1Pre-grant publication · published 4 Nov 2004

US 6,642,360 B2Parent of this continuation

Application09/254,311Parent of this continuation-in-part

PCT/US99/28301Parent of this continuation-in-part

US 2002/0058309 A1Published application

US 2003/0083479 A1Published application

US 7,442,772 B2This patent

From the US filing history. Foreign family members aren’t listed.

Abstract

Facts

Application

10/735,014Filed 12 Dec 2003 · continuation

Priority

25 Feb 1998

Published

US 2004/0220385 A14 Nov 2004

Granted

28 Oct 2008

Term ends

Not estimatedThe source records don’t support an estimate.

Classification4 codes

C07K 14/47
From vertebrates: from mammals
C07K 14/705
From animals; from humans: receptors; Cell surface antigens; Cell surface determinants
C07K 16/18
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies: against material from animals or humans
C07K
Peptides

Family

Application60/075,945Us provisional application · filed 25 Feb 1998

PCT/US98/25108Parent of this continuation-in-part · filed 1 Dec 1998

PCT/US99/28301Parent of this continuation · filed 1 Dec 1999

Application09/866,028Parent of this continuation · filed 25 May 2001

Application09/944,852Parent of this continuation · filed 31 Aug 2001

US 2004/0220385 A1Pre-grant publication · published 4 Nov 2004

US 6,642,360 B2Parent of this continuation

Application09/254,311Parent of this continuation-in-part

PCT/US99/28301Parent of this continuation-in-part

US 2002/0058309 A1Published application

US 2003/0083479 A1Published application

US 7,442,772 B2This patent

From the US filing history. Foreign family members aren’t listed.

Antibodies to PRO361 polypeptide

Life of this patent

Abstract

Claims4

Antibodies to PRO361 polypeptide

Life of this patent

Abstract

Claims4